Business Description
Magle Chemoswed Holding AB
ISIN : SE0014401014
Share Class Description:
OSTO:MAGLE: Ordinary SharesTotal Employee Number:
143Compare
Compare
Traded in other countries / regions
MAGLE.Sweden52X.Germany IPO Date
2020-06-30Description
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Equity-to-Asset | 0.34 | |||||
Debt-to-Equity | 1.27 | |||||
Debt-to-EBITDA | -7.52 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -0.18 | |||||
Beneish M-Score | -3.99 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.2 | |||||
3-Year FCF Growth Rate | -100.8 | |||||
3-Year Book Growth Rate | 2.3 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 35.99 | |||||
9-Day RSI | 25.29 | |||||
14-Day RSI | 23.29 | |||||
3-1 Month Momentum % | -17.14 | |||||
6-1 Month Momentum % | -79.65 | |||||
12-1 Month Momentum % | -87.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.18 | |||||
Quick Ratio | 0.57 | |||||
Days Inventory | 879.07 | |||||
Days Sales Outstanding | 41.89 | |||||
Days Payable | 281.36 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24 | |||||
Shareholder Yield % | -547.6 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 81.13 | |||||
Operating Margin % | -58.12 | |||||
Net Margin % | -66.89 | |||||
EBITDA Margin % | -17.54 | |||||
FCF Margin % | -28.21 | |||||
OCF Margin % | -28.21 | |||||
ROE % | -41.25 | |||||
ROA % | -19.05 | |||||
ROIC % | -14.97 | |||||
3-Year ROIIC % | -28.02 | |||||
ROC (Joel Greenblatt) % | -29.65 | |||||
ROCE % | -22.19 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.08 | |||||
PB Ratio | 0.08 | |||||
Price-to-Tangible-Book | 0.43 | |||||
EV-to-EBIT | -2.74 | |||||
EV-to-EBITDA | -8.24 | |||||
EV-to-Revenue | 1.45 | |||||
EV-to-FCF | -5.13 | |||||
Price-to-GF-Value | 0.04 | |||||
Price-to-Projected-FCF | 0.13 | |||||
Earnings Yield (Greenblatt) % | -36.44 | |||||
FCF Yield % | -369.16 | |||||
Forward Rate of Return (Yacktman) % | 18.99 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Magle Chemoswed Holding AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 270.172 | ||
| EPS (TTM) (kr) | -8.76 | ||
| Beta | 0.3669 | ||
| 3-Year Sharpe Ratio | -1.15 | ||
| 3-Year Sortino Ratio | -1.25 | ||
| Volatility % | 82.76 | ||
| 14-Day RSI | 23.29 | ||
| 14-Day ATR (kr) | 0.212373 | ||
| 20-Day SMA (kr) | 1.314 | ||
| 12-1 Month Momentum % | -87.21 | ||
| 52-Week Range (kr) | 0.865 - 27.8 | ||
| Shares Outstanding (Mil) | 20.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Magle Chemoswed Holding AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Magle Chemoswed Holding AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-13 | In 132 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 132 days | ||
| Second quarter earnings results for 2026 | 2026-07-31 | In 27 days | ||
| General meeting for 2025 | 2026-06-30 15:00 | 1.01 (-2.88%) | ||
| Annual report for 2025 | 2026-06-09 | 2.20 (-32.93%) | ||
| First quarter earnings results for 2026 | 2026-05-31 | 3.50 (-0.57%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-27 | 4.26 (-34.46%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 20.80 (+5.58%) | ||
| Second quarter earnings results for 2025 | 2025-08-01 | 21.20 (+0.00%) | ||
| General meeting for 2024 | 2025-05-26 10:00 | 26.00 (+3.17%) |
Show
Entries
Magle Chemoswed Holding AB Frequently Asked Questions
What is Magle Chemoswed Holding AB(OSTO:MAGLE)'s stock price today?
The current price of OSTO:MAGLE is kr1.00. The 52 week high of OSTO:MAGLE is kr27.80 and 52 week low is kr0.87.
When is next earnings date of Magle Chemoswed Holding AB(OSTO:MAGLE)?
The next earnings date of Magle Chemoswed Holding AB(OSTO:MAGLE) is 2026-07-31 Est..
Does Magle Chemoswed Holding AB(OSTO:MAGLE) pay dividends? If so, how much?
Magle Chemoswed Holding AB(OSTO:MAGLE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Magle Chemoswed Holding AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers